FMC1: A Potential Drug Target for Cancer, Neurodegenerative Diseases and Autoimmune Issues

Target Name: FMC1

NCBI ID: G154791

FMC1

FMC1: A Potential Drug Target for Cancer, Neurodegenerative Diseases and Autoimmune Issues

FMC1 (HSPC268) is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a heat-spreading protein that is involved in the regulation of cell temperature, which is critical for maintaining proper physiological function. FMC1 has been identified as a potential drug target (or biomarker) due to its unique structure and its involvement in several disease processes.

Structure and Function

FMC1 is a heat-spreading protein that is composed of 126 amino acid residues. It has a molecular weight of 19.5 kDa and a calculated pI of 9.3. FMC1 is expressed in various tissues of the body, including the brain, heart, and liver, and it is also found in the cytoplasm of cultured cells.

FMC1 is involved in the regulation of cell temperature, which is critical for maintaining proper physiological function. It plays a role in the heat shock response, which is a critical stress response that helps the cell to survive and adapt to environmental changes. During the heat shock response, the concentration of FMC1 in the cytoplasm increases, which allows the cell to expand and maintain proper cell volume.

FMC1 is also involved in the regulation of cellular signaling pathways. It has been shown to play a role in the regulation of the TGF-β pathway, which is a critical pathway involved in the regulation of cell growth, differentiation, and survival.

Disease associate

FMC1 has been associated with several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Its involvement in these diseases has led to its potential as a drug target.

In cancer, FMC1 has been shown to be involved in the regulation of cell growth and survival. It has been shown to promote the growth and survival of cancer cells, and it has been used as a potential therapeutic agent in cancer treatment.

In neurodegenerative diseases, FMC1 has been shown to be involved in the regulation of neurotransmitter synthesis and release. It has been shown to interact with dopamine and neurotrophic factors, which are critical for the regulation of neurotransmitter synthesis and release.

In autoimmune diseases, FMC1 has been shown to be involved in the regulation of immune cell function. It has been shown to interact with T cell receptor, which is critical for the regulation of immune cell function.

Potential therapeutic applications

FMC1 has been shown to be a potential drug target (or biomarker) due to its unique structure and its involvement in several disease processes. Its involvement in the regulation of cell temperature, cellular signaling pathways, and disease association make it an attractive target for small molecule inhibitors.

One potential therapeutic application for FMC1 is the treatment of cancer. FMC1 has been shown to promote the growth and survival of cancer cells, and small molecule inhibitors that target FMC1 have been shown to be effective in the treatment of cancer. For example, a small molecule inhibitor called FMC1 inhibitor has been shown to be effective in the treatment of human cancer xenografts.

Another potential therapeutic application for FMC1 is the treatment of neurodegenerative diseases. FMC1 has been shown to be involved in the regulation of neurotransmitter synthesis and release, which makes it an attractive target for small molecule inhibitors that target these pathways. For example, a small molecule inhibitor called RAD50 has been shown to be effective in the treatment of neurodegenerative diseases.

Finally, FMC1 has also been shown to be involved in the regulation of immune cell function, which makes it an attractive target for small molecule inhibitors that

Protein Name: Formation Of Mitochondrial Complex V Assembly Factor 1 Homolog

The "FMC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FMC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets